Mark Bachleda - Net Worth and Insider Trading
Mark Bachleda Net Worth
The estimated net worth of Mark Bachleda is at least $327 dollars as of 2024-12-25. Mark Bachleda is the Chief Commercial Officer of Galera Therapeutics Inc and owns about 11,000 shares of Galera Therapeutics Inc (GRTX) stock worth over $327. Details can be seen in Mark Bachleda's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Bachleda has not made any transactions after 2023-03-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Bachleda
Mark Bachleda Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Bachleda owns 1 companies in total, including Galera Therapeutics Inc (GRTX) .
Click here to see the complete history of Mark Bachleda’s form 4 insider trades.
Insider Ownership Summary of Mark Bachleda
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GRTX | Galera Therapeutics Inc | 2023-03-16 | Chief Commercial Officer |
Mark Bachleda Latest Holdings Summary
Mark Bachleda currently owns a total of 1 stock. Mark Bachleda owns 11,000 shares of Galera Therapeutics Inc (GRTX) as of March 16, 2023, with a value of $327.
Latest Holdings of Mark Bachleda
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GRTX | Galera Therapeutics Inc | 2023-03-16 | 11,000 | 0.03 | 327 |
Holding Weightings of Mark Bachleda
Mark Bachleda Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Bachleda has made a total of 1 transactions in Galera Therapeutics Inc (GRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Galera Therapeutics Inc is the acquisition of 11,000 shares on March 16, 2023, which cost Mark Bachleda around $24,750.
Insider Trading History of Mark Bachleda
- 1
Mark Bachleda Trading Performance
GuruFocus tracks the stock performance after each of Mark Bachleda's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Bachleda is 39.5%. GuruFocus also compares Mark Bachleda's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Bachleda within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Bachleda's insider trading performs compared to the benchmark.
Performance of Mark Bachleda
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 26.48 | | | | | |
| Relative Return to S&P 500(%) | 22 | | | | | |
Mark Bachleda Ownership Network
Mark Bachleda Owned Company Details
What does Galera Therapeutics Inc do?
Who are the key executives at Galera Therapeutics Inc?
Mark Bachleda is the Chief Commercial Officer of Galera Therapeutics Inc. Other key executives at Galera Therapeutics Inc include director & President and CEO Mel Sorensen , Chief Financial Officer Chris Degnan , and Chief Medical Officer Eugene P. Kennedy .
Galera Therapeutics Inc (GRTX) Insider Trades Summary
Over the past 18 months, Mark Bachleda made no insider transaction in Galera Therapeutics Inc (GRTX). Other recent insider transactions involving Galera Therapeutics Inc (GRTX) include a net purchase of 3,712,809 shares made by , and a net sale of 67,015 shares made by Mel Sorensen .
In summary, during the past 3 months, insiders sold 0 shares of Galera Therapeutics Inc (GRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 67,015 shares of Galera Therapeutics Inc (GRTX) were sold and 3,712,809 shares were bought by its insiders, resulting in a net purchase of 3,645,794 shares.
Galera Therapeutics Inc (GRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galera Therapeutics Inc Insider Transactions
Mark Bachleda Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Bachleda. You might contact Mark Bachleda via mailing address: C/o Galera Therapeutics, Inc., 2 W Liberty Boulevard, #110, Malvern Pa 19355.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
